Deferoxamine for system suitability CRS (Y0001934)
| Product Name | Deferoxamine for system suitability CRS (Y0001934) |
|---|---|
| Alternate Names | - EP Standards, EP Standards of - |
| CAT No. | CS-EG-03189 |
| CAS No. | 70-51-9 |
| Category | EP Standards |
| Stock | Enquire |
| Mol. Wt. | - g/mol |
| Mol. For. | - |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
Artichoke Leaf Dry Extract | Alfuzosin System Suitability A CRS (Containing Impurity B,F & G) | Insulin Aspart | Pantoprazole SST for peak identification(A,B,C,D,E,F) | FORMOTEROL FUMARATE FOR SYSTEM SUITABILITY | Sucralose (Y0001344) | Alpha -Tocopheryl acetate for stability | Phenylephrine hydrochloride for peak identification CRS (containing impurities C and E) | ALFUZOSIN SYSTEM SUITABILITY MIXTURE A CONTAINING A,D,E | Nicergoline EP Impurity D | Glimepiride for System Suitability CRS containing impurities B, C & D | Adapalene peak identification CRS(impurity A, C and D | Cyanocobalamine For Peak Identification (Containing Impurity B & D) | BENZYL PENCILLIN FOR PEAK IDENTIFICATION (ACRS) CONTAINING IMPURITIES B,C,D,E,F,G,H,I,J | Cyanocobalamine For System Suitability CRS (Containing Impurities A,C,E & F) | Supelco 37 Component FAME Mix | Miconazole for peak identification CRS Containing impurity C&F | Mexifloxacin for system suitability(contain impurity G) | Caffeine for system suitability CRS (containing impurities A, C, D and F) | Methotrexate System Suitability Mixture(Methotrexate,Methotrexate related compound I,Methotrexate related compound H) | Mexifloxacin for peak identification A(contain impurity A,B and G) | Salbutamol for peak identification(Y0002386) | Alfuzosin Peak Identification CRS (Containing Impurities D) | Citalopram for system suitability CRS (Contaning B,D & G) | rivaroxaban for system suitability CRS (containing impurity G) |